Develops biotechnology products in China.
Dec 2025Revenue $16.6M/yrExpenses $26.7M/yr
Fell below break-even Mar 2025
Figures by year
When will Zhengye Biotechnology Holding be profitable again?
Its expenses passed its revenue in Mar 2025. In the 12 months to Dec 2025, revenue was $16.6M and expenses $26.7M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $16.6M | $26.7M | −$10.1M |
| Dec 2024 | $25.5M | $23.3M | $2.25M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.